• Home
  • Suanfarma
  • Revolutionizing Pharma Manufacturing With TT&GO® Technology Transfer
Video
23 Oct 2024

Revolutionizing Pharma Manufacturing With TT&GO® Technology Transfer

In the rapidly evolving landscape of pharmaceutical manufacturing, the TT&GO® platform by Suanfarma CDMO stands out as a revolutionary solution for technology transfer. This session will explore into the unique methodology of TT&GO®, which integrates rigorous, systematic procedures grounded in risk-based analysis to facilitate seamless technology transfers.

  • Methodological rigor and flexibility: Understanding the systematic approach of TT&GO® that applies to various phases of the product lifecycle, ensuring adaptability and compliance with Good Manufacturing Practices (GMP).
  • Risk management and cost efficiency: Analyzing how TT&GO®'s proactive risk assessment and mitigation strategies lead to reduced failure rates and cost savings, empowering clients to pursue ambitious project timelines with minimized risks.
  • Real-world applications and outcomes: Presenting case studies and success stories of TT&GO® in action, highlighting the platform's impact on accelerating commercial launches and enhancing market competitiveness.
  • Attendees of this session can expect to leave with a comprehensive understanding of how advanced technology transfer methodologies like TT&GO® can be leveraged to optimize pharmaceutical manufacturing processes, ensuring higher efficiency, reduced risk, and better overall outcomes.

    • Content provided by our supplier

    Suanfarma

    • Country/Region:
      Spain
    • On CPHI since:
      2015
    • Certificates:
      3
    • Employees:
      250 - 499
    Company types
    CMO/CDMO
    Distributor/Import Export
    Manufacturer/Innovator
    Primary activities
    API Producer
    Contract Manufacturer
    View company profile

    Other Content from Suanfarma (3)

    • Suanfarma and the Fight Infections Foundation: a strategic collaboration to advance global health

      News Suanfarma and the Fight Infections Foundation: a strategic collaboration to advance global health

      Suanfarma has initiated a collaboration with the Fight Infections Foundation, an internationally renowned organization with more than three decades of scientific leadership in the study, prevention, and treatment of infectious diseases. This alliance is born from a shared vision: combining capabilities and exploring ways of working together to contribute to global health.
      11 Mar 2026
    • Suanfarma Appoints Pere Mañé as New CEO to Drive Industrial Growth and Global Expansion

      News Suanfarma Appoints Pere Mañé as New CEO to Drive Industrial Growth and Global Expansion

      Suanfarma has announced the appointment of Pere Mañé Godina as its new Chief Executive Officer (CEO). This marks the beginning of a new chapter for the company, focused on industrial consolidation, sustainable innovation, and global expansion
      23 Apr 2025
    • Suanfarma, At the Core of a Better Life

      Video Suanfarma, At the Core of a Better Life

      Suanfarma is a key player in the life sciences sector, specializing in the development of active pharmaceutical ingredients (APIs) and contract development and manufacturing (CDMO) services. Since 1993, Suanfarma has been dedicated to enhancing global health by improving access to affordable medicines. We operate advanced facilities in Portugal and Italy, and supports over 400 laboratories worldwide through a robust network of 12 commercial offices.

      Suanfarma’s proprietary APIs are developed using cutting-edge techniques, including AI and Flow Chemistry, ensuring high standards and GMP compliance. We are committed to sustainability and global health, offering innovative solutions for High Potency APIs and expanding fermentation and chemical synthesis capacities to meet growing global demand. 

      Our customer-centric approach and strong focus on quality makes us a trusted partner in the pharmaceutical industry.

      ...
      2024-10-16